Comfort Conditioning announced the expansion of its commercial service offerings to include process piping for supporting industrial and commercial facilities across North Texas. The addition of ...

The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

POWAY, Calif.--(BUSINESS WIRE)--Cellipont Bioservices (Cellipont), a cell therapy contract development and manufacturing organization (CDMO), announced a strategic debt facility investment from ...

MINNEAPOLIS--(BUSINESS WIRE)--Evolve Additive Solutions Inc., whose proprietary STEP ™ (Selective Thermoplastic Electrophotographic Process) technology is the first scaled volume production-ready ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...

Analyst Insight: Cell and gene therapies (CGT) provide highly personalized solutions for previously incurable genetic conditions and chronic diseases. While allogeneic CGT relies on a source of cells ...

Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...

A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through GMP manufacturing and commercial supply.